Search Within

Andrew D Zelenetz

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (65)
  2. Journal Article (61)
  3. Research Letter (1)
Groups
  1. Biostatistics Service (127)
  2. Center for Hematologic Malignancies (127)
  3. Department of Medicine (127)
  4. Epidemiology and Biostatistics (127)
  5. Hematologic Malignancies, Division of (127)
  6. Lymphoma (127)

More Groups

People
  1. Craig Moskowitz (66)
  2. Paul Hamlin (56)
  3. Anas Younes (51)
  4. Ariela Noy (49)
  5. David Straus (48)
  6. Anita Kumar (47)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (9)
  4. 2022 (5)
  5. 2021 (11)
  6. 2020 (8)

More Years

Publications
  1. Blood (52)
  2. Journal of Clinical Oncology (13)
  3. Hematological Oncology (10)
  4. British Journal of Haematology (8)
  5. Blood Advances (5)
  6. Blood Cancer Journal (5)

More Publications

Publishers
  1. American Society of Hematology (57)
  2. American Society of Clinical Oncology (13)
  3. Wiley Blackwell (10)
  4. Nature Publishing Group (9)
  5. John Wiley & Sons (8)
  6. Elsevier Inc. (7)

More Publishers

Results (127)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic landscape of diffuse large B-cell lymphoma (DLBCL) using a novel diagnostic targeted sequencing platform
    Meeting Abstract

    Setoodeh, I.; Teruya-Feldstein, J.; Seshan, V.; Levine, R.; Zelenetz, A.; Palomba, L.; Moskowitz, C.; Van Den Brink, M.; Knapp, K.; Copeland, A.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma
    Journal Article

    Ulaner, G. A.; Lilienstein, J.; Gonen, M.; Maragulia, J.; Moskowitz, C. H.; Zelenetz, A. D.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A Phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with BCell lymphoid malignancies: Favorably durable event-free survival in chemosensitive patients
    Journal Article

    Sauter, C. S.; Barker, J. N.; Lechner, L.; Zheng, J.; Devlin, S. M.; Papadopoulos, E. B.; Perales, M. A.; Jakubowski, A. A.; Goldberg, J. D.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Association of quantitative assessment of the intrafollicular proliferation index with outcome in follicular lymphoma
    Journal Article

    Kedmi, M.; Hedvat, C. V.; Maragulia, J.; Zhang, Z.; Zelenetz, A. D.
    British Journal of Haematology (2014)

    Fulltext@MSK | Save
  • ABT-888 plus bendamustine is safe and has shown preliminary efficacy in patients with lymphoma
    Meeting Abstract

    Gerecitano, J. F.; Schwartz, G. K.; Carvajal, R.; Fury, M.; Konner, J.; Hyman, D. M.; Gounder, M.; Gajria, D.; Teitcher, J.; Zhang, Z.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Profiling genomic alterations of diffuse large B-cell lymphoma (DLBCL) at diagnosis, relapse, and transformation, using a novel clinical diagnostic targeted sequencing platform
    Meeting Abstract

    Intlekofer, A. M.; Sheshan, V. E.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; van den Brink, M. R. M.; Knapp, K. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma
    Journal Article

    Burger, I. A.; Vargas, H. A.; Goldman, D. A.; Gonen, M.; Kumar, A.; Zelenetz, A. D.; Schòˆder, H.; Hricak, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2013)

    Fulltext@MSK | Save
  • Indications for and efficacy of splenectomy for haematological disorders
    Journal Article

    Bickenbach, K. A.; Gonen, M.; Labow, D. M.; Strong, V.; Heaney, M. L.; Zelenetz, A. D.; Coit, D. G.
    British Journal of Surgery (2013)

    Fulltext@MSK | Save
  • Final results of phase I/II trial of vorinostat in combination with cyclophosphamide, etoposide, prednisone, and rituximab (R-CVEP) for elderly patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Straus, D. J.; Hamlin, P. A.; Matasar, M. J.; Palomba, M. L.; Drullinsky, P.; Zelenetz, A. D.; Gerecitano, J. F.; Noy, A.; Hamilton, A. M.; Wegner, B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma
    Journal Article

    Schatz, J. H.; Oricchio, E.; Wolfe, A. L.; Jiang, M.; Linkov, I.; Maragulia, J.; Shi, W.; Zhang, Z.; Rajasekhar, V. K.; Pagano, N. C.; more...
    Journal of Experimental Medicine (2011)

    Fulltext@MSK | Save